Galgóczi Erika

University of Debrecen

Central Units of UD

Medical Center

Internal Medicine

A Building of Internal Medicine

2024-

Name: Galgóczi Erika

Affiliation:

Debreceni Egyetem. A DE Központi Egységei. Klinikai Központ. Belgyógyászati Klinika. A épület (Belgyógyászati Klinika) / University of Debrecen. Central Units of UD. Medical Center. Internal Medicine. A Building of Internal Medicine

Degree:

PhD, Debreceni Egyetem (2021)

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2013-2025

2025

Galgóczi, E., Orsós, I., Molnár, Z., Ujhelyi, B., Steiber, Z., Szabó, L., Dienes, B., Csernoch, L., Nagy, E. V., Katkó, M.: Stimulation of Piezo1 Mechanosensitive Channels Inhibits Adipogenesis in Thyroid Eye Disease.
J. Clin. Endocrinol. Metab. [Epub ahead of print], 2025.

doi DEA WoS

Journal metrics:

D1 Biochemistry (2024)

D1 Biochemistry (medical) (2024)

D1 Clinical Biochemistry (2024)

D1 Endocrinology (2024)

D1 Endocrinology, Diabetes and Metabolism (2024)

D1 Medicine (miscellaneous) (2024)

2024

Papp, F. R., Csiki, R., Katkó, M., Galgóczi, E., Steiber, Z., Ujhelyi, B., Nagy, E. V.: Characteristics of hyaluronan metabolism during myofibroblast differentiation in orbital fibroblasts.
EJEA. 101, 20, 2024.

doi DEA

Papp, F. R., Katkó, M., Csiki, R., Galgóczi, E., Molnár, Z., Erdei, A., Bodor, M., Steiber, Z., Ujhelyi, B., Nagy, E. V.: Characteristics of Hyaluronan Metabolism During Myofibroblast Differentiation in Orbital Fibroblasts.
Invest. Ophthalmol. Vis. Sci. 65 (13), 1-12, (article identifier: 13), 2024.

doi DEA

Journal metrics:

Q2 Cellular and Molecular Neuroscience

Q1 Ophthalmology

Q1 Sensory Systems

Galgóczi, E., Molnár, Z., Katkó, M., Ujhelyi, B., Steiber, Z., Nagy, E. V.: Cyclosporin A inhibits PDGF-BB induced hyaluronan synthesis in orbital fibroblasts.
Chem.-Biol. Interact. 396, 1-7, (article identifier: 111045), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Medicine (miscellaneous)

Q1 Toxicology

Galgóczi, E., Orsós, I., Molnár, Z., Ujhelyi, B., Steiber, Z., Szabó, L., Dienes, B., Csernoch, L., Nagy, E. V., Katkó, M.: Modelling of mechanical stimuli through piezo1 receptor activation and its effect on adipogenic differentiation of orbital fibroblasts.
EJEA. 101, 37, (article identifier: 0101), 2024.

doi DEA

Csiki, R., Papp, F. R., Galgóczi, E., Steiber, Z., Ujhelyi, B., Nagy, E. V., Katkó, M.: Production of chemerin by orbital fibroblasts during myofibroblast and adipocyte differentiation.
EJEA. 101, 38, 2024.

doi DEA

2022

Frendl, I., Erdei, A., Zsíros, N., Katkó, M., Galgóczi, E., Németi, Z., Bhattoa, H. P., Kappelmayer, J., Posta, J., Turchányi, B., Urbán, F., Nagy, E. V.: Alcohol consumption affects the late endocrine consequences of mild traumatic brain injury.
Neuroendocrinol. Lett. 43 (4), 239-245, 2022.

DEA WoS Scopus

Journal metrics:

Q4 Endocrine and Autonomic Systems

Q4 Endocrinology

Q4 Endocrinology, Diabetes and Metabolism

Q4 Medicine (miscellaneous)

Q4 Neurology

Q4 Neurology (clinical)

Q4 Psychiatry and Mental Health

Aranyosi, J. K., Galgóczi, E., Erdei, A., Katkó, M., Fodor, M., Ujhelyi, Z., Bácskay, I., Nagy, E. V., Ujhelyi, B.: Different Effects of Cigarette Smoke, Heated Tobacco Product and E-Cigarette Vapour on Orbital Fibroblasts in Graves' Orbitopathy; a Study by Real Time Cell Electronic Sensing.
Molecules. 27 (9), 1-14, 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Analytical Chemistry

Q2 Chemistry (miscellaneous)

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q3 Molecular Medicine

Q2 Organic Chemistry

Q1 Pharmaceutical Science

Q2 Physical and Theoretical Chemistry

Galgóczi, E., Katkó, M., Papp, F. R., Csiki, R., Csiha, S., Erdei, A., Bodor, M., Ujhelyi, B., Steiber, Z., Győry, F., Nagy, E. V.: Glucocorticoids Directly Affect Hyaluronan Production of Orbital Fibroblasts: a Potential Pleiotropic Effect in Graves' Orbitopathy.
Molecules. 28 (1), 1-12, (article identifier: 15), 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Analytical Chemistry

Q2 Chemistry (miscellaneous)

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q3 Molecular Medicine

Q2 Organic Chemistry

Q1 Pharmaceutical Science

Q2 Physical and Theoretical Chemistry

10.

Lőrincz, H., Galgóczi, E., Katkó, M., Ratku, B., Ötvös, T., Harangi, M., Paragh, G., Szabó, Z., Somodi, S.: Plasminogen activator inhibitor-1 level associated with the components of metabolic syndrome in a 4G/5G polymorphism dependent manner.
Atherosclerosis. 355, e248, 2022.

doi DEA

11.

Galgóczi, E., Katkó, M., Erdei, A., Bodor, M., Ujhelyi, B., Steiber, Z., Győry, F., Nagy, E. V.: The effect of glucocorticoids on hyaluronan production of orbital fibroblasts.
Endocrine Abst. 84, PS2-07-64, 2022.

doi DEA

12.

Katkó, M., Gazdag, A., Harangi, M., Szentpéteri, A., Galgóczi, E., Erdei, A., Berta, E., Bodor, M., Bhattoa, H. P., Nagy, E. V.: The effect of iatrogenic hypothyroidism on lipoprotein subfractions and serum paraoxonase activity in patients with differentiated thyroid cancer.
Atherosclerosis. 355, e163, 2022.

doi DEA

2021

13.

Katkó, M., Galgóczi, E., Erdei, A., Gazdag, A., Berta, E., Bodor, M., Seres, I., Hircsu, I., Badics, Á., Ujhelyi, B., Sira, L., Bhattoa, H. P., Nagy, E. V.: The 4G/5G Polymorphism of Plasminogen Activator Inhibitor Type 1 is a Predictor of Moderate-to-Severe Thyroid Eye Disease.
J. Inflamm. Res. 14, 1883-1890, 2021.

doi DEA

Journal metrics:

Q2 Immunology

Q2 Immunology and Allergy

2020

14.

Galgóczi, E., Jeney, F., Katkó, M., Erdei, A., Gazdag, A., Sira, L., Bodor, M., Berta, E., Ujhelyi, B., Steiber, Z., Győry, F., Nagy, E. V.: Characteristics of Hyaluronan Synthesis Inhibition by 4-Methylumbelliferone in Orbital Fibroblasts.
Invest. Ophthalmol. Vis. Sci. 61 (2), 1-8, 2020.

doi DEA WoS Scopus

Journal metrics:

Q1 Cellular and Molecular Neuroscience

D1 Ophthalmology

Q1 Sensory Systems

2019

15.

Sumanszki, C., Kiss, E., Simon, E., Galgóczi, E., Soós, Á., Patócs, A., Kovács, B., Nagy, E. V., Reismann, P.: Iodine and selenium status in adult PKU.
Endocrine Abstracts. 63, P781, 2019.

doi DEA

16.

Sumanszki, C., Kiss, E., Simon, E., Galgóczi, E., Soós, Á., Patócs, A., Kovács, B., Nagy, E. V., Reismann, P.: The Association of Therapy Adherence and Thyroid Function in Adult Patients with Phenylketonuria.
Ann. Nutr. Metab. 75 (1), 16-23, 2019.

doi DEA

Journal metrics:

Q1 Medicine (miscellaneous)

Q2 Nutrition and Dietetics

2017

17.

Frendl, I., Katkó, M., Galgóczi, E., Boda, J., Zsíros, N., Németi, Z., Bereczky, Z., Hudák, R., Kappelmayer, J., Erdei, A., Turchányi, B., Nagy, E. V.: Plasminogen Activator Inhibitor Type 1: a Possible Novel Biomarker of Late Pituitary Dysfunction after Mild Traumatic Brain Injury.
J. Neurotrauma. 34 (23), 3238-3244, 2017.

doi DEA

Journal metrics:

D1 Neurology (clinical)

2016

18.

Galgóczi, E., Jeney, F., Gazdag, A., Erdei, A., Katkó, M., M. Nagy, D., Ujhelyi, B., Steiber, Z., Győry, F., Berta, E., Nagy, E. V.: Cell density dependent stimulation of PAI-1 and hyaluronan synthesis by TGF-[béta] in orbital fibroblasts.
J. Endocrinol. 229 (2), 187-196, 2016.

doi DEA

Journal metrics:

Q1 Endocrinology

D1 Endocrinology, Diabetes and Metabolism

2013

19.

Sámson, L., M. Nagy, D., Galgóczi, E., Gazsó, A., Czégény, I., Katkó, M., Nagy, E. V.: A hálózati ivóvíz, mint jódforrás.
In: Fiatal kutatók az egészséges élelmiszerért. Szerk.: Bódi Éva, Fekete István, Kovács Béla, Debreceni Egyetem Hankóczy Jenő Növénytermesztési, Kertészeti és Élelmiszertudományok Doktori Iskola, Debrecen, 270-275, 2013. ISBN: 9789634736011

DEA